Helicobacter pylori infection disease
Conditions
Interventions
trial group:orally administered bovine anti-H pylori antibodie
control group:orally administered bovine anti-H pylori antibodie
Sponsors
Shan baoen
Eligibility
Sex/Gender
All
Age
22 Years to 78 Years
Inclusion criteria
Inclusion criteria: more than 18 years old, no previous treatment for the Helicobacter pylori infection, not having a chronic decompensated, no use of anti-inflammatory or antibiotic drugs within 4 weeks prior to enrollment.
Exclusion criteria
Exclusion criteria: Lactose intolerance, pregnancy or lactation, significant systemic comorbidity, patients over 80 years or with a history of gastrointestinal surgery and patients with erosive esophagitis or users of low-dose aspirin. Patients who had difficulty in understanding the treatment or reporting disease symptoms and adverse effects were also excluded.use of antibiotics within four weeks before the start of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| C14-urea breath tes; | — |
Countries
China
Contacts
Public ContactShan baoen
Outcome results
None listed